SRC and neoplasm: Abnormal expression or activation of CSK has been documented to have vital roles in tumor malignancy and interacted with mechanisms that regulate paclitaxel sensitivity.29 Thus we wondered whether c-Src/Stat3/HIF-1α pathway was also aroused in hypoxic resistance to paclitaxel.